Last updated on April 2018

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma


Brief description of study

This study seeks to evaluate the tolerability, pharmacokinetics (PK), efficacy, and safety of ABT-414 in Japanese participants with newly diagnosed and recurrent, World Health Organization (WHO) grade III or IV malignant glioma.

Clinical Study Identifier: NCT02590263

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )